1 week Ago By Defense World Staff
Envestnet Asset Management Inc. cut its position in shares of Stevanato Group S.p.
A. (NYSE:STVN – Free Report) by 50.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
The fund owned 139,225 shares of the company’s stock after selling 139,697 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Stevanato Group were worth $3,034,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of STVN. Van Berkom & Associates Inc. bought a new position in Stevanato Group during the fourth quarter valued at approximately $39,000.
Wells Fargo & Company MN grew its holdings in shares of Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock valued at $71,000 after purchasing an additional 2,830 shares during the last quarter.
PNC Financial Services Group Inc. raised its position in Stevanato Group by 1,457.6% in the 4th quarter.
PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after purchasing an additional 5,291 shares during the period. US Bancorp DE raised its position in Stevanato Group by 17.
9% in the 4th quarter. US Bancorp DE now owns 8,527 shares of the company’s stock worth $186,000 after purchasing an additional 1,295 shares during the period. Finally, Marco Investment Management LLC bought a new stake in Stevanato Group in the fourth quarter worth $203,000.
Stevanato Group Trading Down 2.0 %STVN opened at €21.46 ($24.
39) on Friday. Stevanato Group S.p.
A. has a one year low of €16.56 ($18.
82) and a one year high of €28.77 ($32.69).
The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.
21. The business has a 50 day simple moving average of €20.76 and a two-hundred day simple moving average of €20.
74. The firm has a market capitalization of $6.50 billion, a price-to-earnings ratio of 45.
66, a PEG ratio of 7.18 and a beta of 0.52.
Stevanato Group (NYSE:STVN – Get Free Report) last announced its earnings results on Thursday, March 6th. The company reported €0.20 ($0.
23) EPS for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.23).
The company had revenue of €352.68 million during the quarter, compared to the consensus estimate of €346.26 million.
Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%.
Analysts predict that Stevanato Group S.p.A.
will post 0.5 EPS for the current year. Analyst Upgrades and DowngradesSeveral research analysts have recently commented on the company.
UBS Group decreased their price objective on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a report on Friday, March 7th.
William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th. Finally, Stephens raised Stevanato Group to a “strong-buy” rating in a research note on Monday, April 21st. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock.
Based on data from MarketBeat, Stevanato Group currently has an average rating of “Moderate Buy” and a consensus price target of €25.70 ($29.20).
Get Our Latest Stock Analysis on Stevanato GroupStevanato Group Company Profile (Free Report)Stevanato Group S.p.A.
engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.Featured StoriesFive stocks we like better than Stevanato GroupWhat is Insider Trading? What You Can Learn from Insider TradingShort Sellers Gave Up on These 3 Names RecentlyHow to Start Investing in Real Estate3 Boring Stocks Outperforming the Market This Year3 Grocery Stocks That Are Proving They Are Still Essential If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To BuyWant to see what other hedge funds are holding STVN? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Stevanato Group S.p.A.
(NYSE:STVN – Free Report)..
